As shown in Tables 4 and 5, the interactions of an increased serum folate level with unmethylated p16 and p53 promoter regions was significantly associated with a reduced risk of both EPL and ESCC (p for interaction < 0.05). This evidence concerns the gene CDKN2A and esophageal squamous cell carcinoma.